Condition: Gastrointestinal Malignancy · Sponsor: University of Auckland, New Zealand
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
This description comes directly from the study's public registry record.
Jade Scott · +64 (0)9 923 4222 · j.scott@auckland.ac.nz
Sarah Benge · +64276045647 · s.benge@auckland.ac.nz
Always discuss trial participation with your own doctor first.
| Auckland City Hospital | Auckland, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06538610